These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Treatment of brain edema with a nonpeptide arginine vasopressin V1 receptor antagonist OPC-21268 in rats. Bemana I; Nagao S Neurosurgery; 1999 Jan; 44(1):148-54; discussion 154-5. PubMed ID: 9894975 [TBL] [Abstract][Full Text] [Related]
3. Treatment of vasogenic brain edema with arginine vasopressin receptor antagonist--an experimental study. Nagao S; Kagawa M; Bemana I; Kuniyoshi T; Ogawa T; Honma Y; Kuyama H Acta Neurochir Suppl (Wien); 1994; 60():502-4. PubMed ID: 7976630 [TBL] [Abstract][Full Text] [Related]
4. Arginine vasopressin receptor antagonists for treatment of vasogenic brain edema: an experimental study. Kagawa M; Nagao S; Bemana I J Neurotrauma; 1996 May; 13(5):273-9. PubMed ID: 8797177 [TBL] [Abstract][Full Text] [Related]
5. [The effect of arginine vasopressin receptor antagonist on the rat cold-injured brain]. Kagawa M; Nagao S No Shinkei Geka; 1993 Dec; 21(12):1103-7. PubMed ID: 8259220 [TBL] [Abstract][Full Text] [Related]
6. Treatment of cold injury-induced brain edema with a nonspecific matrix metalloproteinase inhibitor MMI270 in rats. Kawai N; Kawanishi M; Okada M; Matsumoto Y; Nagao S J Neurotrauma; 2003 Jul; 20(7):649-57. PubMed ID: 12908926 [TBL] [Abstract][Full Text] [Related]
7. Blood pressure-lowering effect of an orally active vasopressin V1 receptor antagonist in mineralocorticoid hypertension in the rat. Burrell LM; Phillips PA; Stephenson JM; Risvanis J; Rolls KA; Johnston CI Hypertension; 1994 Jun; 23(6 Pt 1):737-43. PubMed ID: 8206571 [TBL] [Abstract][Full Text] [Related]
8. OPC-21268, a vasopressin V1 antagonist, produces hypotension in spontaneously hypertensive rats. Yamada Y; Yamamura Y; Chihara T; Onogawa T; Nakamura S; Yamashita T; Mori T; Tominaga M; Yabuuchi Y Hypertension; 1994 Feb; 23(2):200-4. PubMed ID: 8307629 [TBL] [Abstract][Full Text] [Related]
9. Effect of a nonpeptide vasopressin V1 antagonist (OPC-21268) on experimental accelerated focal glomerulosclerosis. Kurihara I; Saito T; Obara K; Shoji Y; Hirai M; Soma J; Sato H; Imai Y; Abe K Nephron; 1996; 73(4):629-36. PubMed ID: 8856262 [TBL] [Abstract][Full Text] [Related]
10. Protective effect of a vasopressin-1 selective antagonist, OPC-21268, against ethanol-induced damage of the rat gastric wall. Sugimoto I; Narimiya N; Odagiri M; Ohnishi A; Tanaka T Dig Dis Sci; 1999 Mar; 44(3):503-9. PubMed ID: 10080141 [TBL] [Abstract][Full Text] [Related]
11. Effects of an oral vasopressin receptor antagonist (OPC-31260) in a dog with syndrome of inappropriate secretion of antidiuretic hormone. Fleeman LM; Irwin PJ; Phillips PA; West J Aust Vet J; 2000 Dec; 78(12):825-30. PubMed ID: 11194468 [TBL] [Abstract][Full Text] [Related]
12. Inhibition of vasopressin action in vascular smooth muscle by the V1 antagonist OPC-21268. Li X; Kribben A; Wieder ED; Tsai P; Nemenoff RA; Schrier RW Hypertension; 1994 Feb; 23(2):217-22. PubMed ID: 8307632 [TBL] [Abstract][Full Text] [Related]
16. Effects of an orally active vasopressin V1 receptor antagonist. Burrell LM; Phillips PA; Stephenson J; Risvanis J; Hutchins AM; Johnston CI Clin Exp Pharmacol Physiol; 1993 May; 20(5):388-91. PubMed ID: 8391950 [TBL] [Abstract][Full Text] [Related]
17. The effect of vasopressin V1- and V2-receptor antagonists on hemodynamics in early and late phase after myocardial infarction in rats. Fujita H; Yoshiyama M; Takeuchi K; Omura T; Yamagishi H; Iwao H; Miura K; Yoshikawa J Jpn J Pharmacol; 1998 Oct; 78(2):229-32. PubMed ID: 9829627 [TBL] [Abstract][Full Text] [Related]
18. Characterization of a novel non-peptide vasopressin V1 receptor antagonist (OPC-21268) in the rat. Burrell LM; Phillips PA; Stephenson J; Risvanis J; Hutchins AM; Johnston CI J Endocrinol; 1993 Aug; 138(2):259-66. PubMed ID: 8228734 [TBL] [Abstract][Full Text] [Related]
19. Treatment of cold injury-induced brain edema with a nonspecific matrix metalloproteinase inhibitor MMI270 in rats. Kawai N; Kawanishi M; Nagao S Acta Neurochir Suppl; 2003; 86():291-5. PubMed ID: 14753455 [TBL] [Abstract][Full Text] [Related]
20. Effects of oral AVP receptor antagonists OPC-21268 and OPC-31260 on congestive heart failure in conscious dogs. Naitoh M; Suzuki H; Murakami M; Matsumoto A; Arakawa K; Ichihara A; Nakamoto H; Oka K; Yamamura Y; Saruta T Am J Physiol; 1994 Dec; 267(6 Pt 2):H2245-54. PubMed ID: 7810724 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]